By: Benzinga
January 30, 2013 at 14:00 PM EST
UPDATE: Goldman Sachs Raises PT to $32 on Pfizer on Breakup Optionality
Goldman Sachs maintained Pfizer, Inc. (NYSE: PFE ) with a Buy rating and raises the price target from $30.00 to $32.00. Goldman Sachs commented, "PFE reported 4Q12 earnings and gave 2013 financial guidance which included highlighting efforts to optimize both the innovation-driven and value-based businesses as distinct entities. On the
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here